For the quarter ended December 2025, Elanco Animal Health Incorporated (ELAN) reported revenue of $1.14 billion, up 12.2% over the same period last year. EPS came in at $0.13, compared to $0.14 in the year-ago quarter.
The reported revenue represents a surprise of +4.72% over the Zacks Consensus Estimate of $1.09 billion. With the consensus EPS estimate being $0.11, the EPS surprise was +16.07%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Elanco Animal Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Elanco Animal Health here>>>
Shares of Elanco Animal Health have returned +0.3% over the past month versus the Zacks S&P 500 composite's -1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Oct-22 | |
| Oct-20 | |
| Oct-19 | |
| Oct-14 | |
| Oct-07 | |
| Sep-17 | |
| Sep-15 | |
| Sep-11 | |
| Sep-10 | |
| Sep-10 | |
| Aug-31 | |
| Aug-26 |
Elanco celebrates $120 million expansion of Elwood manufacturing facility
ELAN
St. Joseph News-Press, Mo.
|
| Aug-26 | |
| Aug-07 | |
| Aug-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite